# New isoxazole-based heterocyclic hybrids with dual antimicrobial and antioxidant bioactivity: integrated synthesis, in vitro assessment, and computational exploration

## TL;DR

Scientists created new isoxazole compounds that show strong antimicrobial and antioxidant effects, with some being as effective as existing drugs.

## Contribution

The study introduces novel isoxazole-based hybrids with dual antimicrobial and antioxidant activity, supported by in vitro and computational analysis.

## Key findings

- Compound 5h showed the highest antibacterial potency against Bacillus subtilis and Candida albicans.
- Compound 5g was most effective against Aspergillus flavus.
- Molecular docking confirmed strong interactions between the compounds and microbial proteins.

## Abstract

In the present study, novel isoxazole-based hybrid compounds 5a–h were synthesized with satisfactory yields. Their structure was confirmed by FT-IR, NMR (1H, 13C, 2D), and HRMS. The antimicrobial properties of this class of compounds were thoroughly investigated in vitro against a variety of Gram-positive and Gram-negative bacteria as well as different fungi, both yeast and molds. Their antioxidant ability was also assessed by molybdate reduction assay. The compounds showed excellent antifungal activity, particularly against Aspergillus niger and Fusarium oxysporum, equivalent to that of fluconazole. Among the series, 5d was the most potent antibacterial agent against Escherichia coli (minimal inhibitory concentration, MIC = 2.582 µmol mL−1), whereas the highest potency against Bacillus subtilis was found for 5h (MIC = 0.083 µmol mL−1) which was comparable to the efficacy of ampicillin. With respect to the antifungal activity, 5h showed the lowest MIC value against Candida albicans (MIC = 0.083 µmol mL−1) and A. niger (MIC = 0.083 µmol mL−1), and 5g was the most effective against Aspergillus flavus (MIC = 0.044 µmol mL−1). All hybrids were more effective as compared to fluconazole against F. oxysporum (MIC range: 0.43–0.94 µmol mL−1). Furthermore, assessment of their antioxidant potential shows that compounds 5e and 5g exhibit excellent reducing potency. Molecular docking and dynamic simulations demonstrated that compounds 5a–h, especially 5d, interact strongly and stably with key bacterial and fungal proteins, forming hydrogen bonds, hydrophobic interactions, and water bridges, with minimal root-mean-square fluctuations (RMSF), confirming the structural integrity of the complexes. Additionally, in silico predictions of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADME-Tox) analysis predicted 5d to possess an optimal profile, with high gastrointestinal absorption and minimal toxicity, highlighting it as the lead candidate for the development of broad-spectrum antimicrobial drugs.

This article reports comprehensive research on the synthesis of novel isoxazole-based heterocyclic hybrids, their characterization and the evaluation of their antimicrobial and antioxidant properties, employing both in vitro and in silico approaches.